Rankings
▼
Calendar
LIVN Q3 2021 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena
LIVN
LivaNova PLC
$3B
Q3 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$253M
+5.5% YoY
Gross Profit
$169M
66.6% margin
Operating Income
$16M
6.5% margin
Net Income
-$43M
-17.2% margin
EPS (Diluted)
$-0.82
QoQ Revenue Growth
-4.3%
Cash Flow
Operating Cash Flow
$24M
Free Cash Flow
$21M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$2.2B
Total Liabilities
$891M
Stockholders' Equity
$1.3B
Cash & Equivalents
$182M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$253M
$240M
+5.5%
Gross Profit
$169M
$143M
+18.1%
Operating Income
$16M
-$3M
+607.6%
Net Income
-$43M
-$15M
-194.1%
Revenue Segments
Cardiovascular Segment
$139M
55%
Neuromodulation Segment
$113M
45%
Geographic Segments
UNITED STATES
$144M
57%
Locations Excluding The United States And Europe
$64M
25%
Europe
$46M
18%
← FY 2021
All Quarters
Q4 2021 →